News
US Senate continues uphill battle on patent eligibility bill
Nick Robertson
October 7, 2025
How impactful is the new USPTO director’s S101 decision?
Sarah Speight
October 2, 2025
Amgen Attacks Academics’ False Claims About Biologic Patents
Gene Quinn
September 21, 2025
C4IP Publishes Website Addressing Misinformation Published by I-MAK
Eileen McDermott
September 19, 2025
USPTO gets new director as John Squires secures Senate confirmation
Angela Morris
September 18, 2025
C4IP Urges FTC to Proceed with Caution on Addressing Perceived Drug Pricing Problems
Eileen McDermott
August 19, 2025
Potential impact of US government march-in on Harvard’s patents
Angela Morris
August 12, 2025